Jorge Conde — SPARQNOW

At-a-Glance

General Partner at Andreessen Horowitz, leading investments at the cross-section of biology, computer science, and engineering.
Co-founder and CEO of Knome, a human genome interpretation company acquired in 2015.
Serves on the boards of Andreessen Horowitz portfolio companies including Asimov, Cartography, Dyno, Earli, IDRx, Komodo Health, Octant Bio, and Vicinitas.
Holds an MBA from Harvard Business School, an MS from the Harvard-MIT Division of Health Sciences and Technology, and a BA in Biology from Johns Hopkins University.

Biography

Jorge Conde is a General Partner at Andreessen Horowitz, where he focuses on leading investments at the intersection of biology, computer science, and engineering. He leverages more than 20 years of experience in the life sciences and healthcare sectors, encompassing leadership, operational, and investment roles in both early-stage and commercial companies.